Beta
Flurbiprofen
medication Under reviewA nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with conditions like osteoarthritis and rheumatoid arthritis.
Research summary
Scientific evidence on flurbiprofen in healthy human subjects is limited primarily to low-dose (8.75 mg) formulations for sore throat relief, with systematic reviews of clinical studies reporting low rates of non-haemorrhagic adverse events and no drug-drug interactions identified. Higher-dose studies exist for arthritis patients but not healthy volunteers, leaving a gap in data for general supplementation. Consensus supports its safety for short-term use in healthy adults at low doses, with gastrointestinal and nervous system effects as the most common mild issues.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Flurbiprofen to your stack to report effects
A systematic review of flurbiprofen 8.75 mg dose and risk of adverse events (excluding haemorrhagic) resulting from drug-drug interactions
Not specified in abstract
Bioequivalence of Flurbiprofen Lozenge vs Strepfen
Not specified
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Flurbiprofen to your stack to report effects
A systematic review of flurbiprofen 8.75 mg dose and risk of adverse events (excluding haemorrhagic) resulting from drug-drug interactions
Not specified in abstract
In-depth summary of adverse events associated with Flurbiprofen: A real-world pharmacovigilance study from 2004 to 2024 using the FAERS database.
Yang C, Guo Q, Cheng Y, Liu F, Zhang H, Wang H
No reports yet
Be the first to report this effect and help the community.
Add Flurbiprofen to your stack to report effects
In-depth summary of adverse events associated with Flurbiprofen: A real-world pharmacovigilance study from 2004 to 2024 using the FAERS database.
Yang C, Guo Q, Cheng Y, Liu F, Zhang H, Wang H
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Chronic autoimmune disease causing joint inflammation
European experience with flurbiprofen. A new analgesic/anti-inflammatory agent.
Not specified
Chronic or recurring pain in joints from arthritis, overuse, or inflammation
European experience with flurbiprofen. A new analgesic/anti-inflammatory agent.
Not specified
Research (4 studies)
In-depth summary of adverse events associated with Flurbiprofen: A real-world pharmacovigilance study from 2004 to 2024 using the FAERS database.
Yang C, Guo Q, Cheng Y, Liu F, Zhang H, Wang H
A systematic review of flurbiprofen 8.75 mg dose and risk of adverse events (excluding haemorrhagic) resulting from drug-drug interactions
Not specified in abstract
Bioequivalence of Flurbiprofen Lozenge vs Strepfen
Not specified
European experience with flurbiprofen. A new analgesic/anti-inflammatory agent.
Not specified
Community updates
No updates yet for this supplement.
Be the first to share your experience!